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Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia which it occurs in 1-
2% of the general population.[1] Over 6 million Europeans are suffering  from this arrhythmia, 
and its prevalence is estimated to be at least double in the next 50 years. The prevalence of AF 
increases with age, and is from 0.5% at 40-50 years to 5-15% at 80 years.[2] Clinically, AF is 
associated with increased rates of death, stroke and other thromboembolic events, heart failure 
and hospitalizations,  reduced quality  of  life  and left  ventricular  dysfunction.  In  ischemic-
related stroke and AF patients, emboli are dominantly from the left atrial appendage (LAA). 
Clinical studies have demonstrated that implantation of a LAA occluder can prevent ischemic 
stroke  and  avoid  anticoagulation  therapy  in  the  patients  with  high-risk  bleeding  [3-5]. 
Currently, two different LAA occluders are available. However, it is still unknown whether 
the device can lead to depression or stenosis in PV diameter. In this article, a compression in 
the left inferior pulmonary vein after implantation of a LAA occluder is reported.                   
Case  report                                  
A 76 year old woman with primary hypertension was referred to our hospital  for catheter 
ablation of persistent AF. She was suffering from exertional  dyspnoe since two years ago 
which became more sever since the last 3 months. Persistent AF was initially diagnosed due to 
ischemic stroke on December 2011. Due to high risk of bleeding with anticoagulation,  an 
Amplatzer LAA occluder (puck and disc type, AGA Medical Corp., Minneapolis, MN) was 
implanted in another  hospital.  Transesophageal  echocardiography (TEE) was performed to 
exclude LAA thrombus before ablation procedure which confirmed that the LAA occluder 
was in the LAA. An angio CT of pulmonary veins was performed which showed three and 
two pulmonary veins in the right and left side, respectively. Compressed LIPV was suspected 
with an oval shape appearance in short axis (8 mm in CT angio), the other veins were in 
normal sizes (Figure 1). 
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Figure 1: LAA occluder which narrowed the LIPV ostium
During the ablation study, stable sinus rhythm was at the beginning of the procedure. Two 8.5 
F SL1 sheaths (St. Jude Medical, Inc., MN, USA) were advanced to the left atrium (LA) by a 
modified  Brockenbrough  Technique.  After  transseptal  catheterization,  intravenous  heparin 
was administered to maintain an activated clotting time of 250 to 300 seconds. Additionally, 
continuous infusions of heparinized saline were connected to the transseptal sheaths (flow rate 
of 10 ml/h) to avoid thrombus formation or air embolism. Electroanatomical mapping was 
performed with a 3.5-mm-tip catheter (ThermoCool, Biosense-Webster, Diamond Bar, CA, 
USA) during SR by using CARTO 3 system (Biosense-Webstar, CA, USA). Mapping at the 
ridge  between  the  left  inferior  pulmonary  vein  (LIPV)  and  LAA in  anterior  part  showed 
significant decrease in impedance (about 70-80 Ohm), which suggested the catheter contact to 
the  metal  device  (Figure  2).                                             
Figure 2: Angiography of LIPV shows the compression and narrowing of ostium
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Selective  PV angiography  showed  that  the  right  sided  and  left  superior  pulmonary  veins 
(LSPV) had normal sizes but the LIPV was compressed with the atrial part of the occluder (the 
diameter of the vein in distal part just before the ostium was around 50 percent smaller than 
that  of  its  proximal  part  (Figure  3).                                        
Figure 3: CARTO imaged showed the lower impedance in blue point area (80 Ohm in camparison with 110 in 
other parts), so the RF wasn't delivered in this part
There was no pressure gradient by pulling back from the distal to the LA with a multipurpose 
catheter  7F  (St  Jude  Medical,  USA).  Circumferential  radiofrequency  (RF)  lesions  were 
delivered  at  the  area  with  normal  impedance  that  resulted  in  the  complete  PV  isolation. 
Therefore,  RF ablation was not necessary to deliver at the area with low impedance.  The 
patient discharged home after 24 hours holter monitoring (stable SR) with Dabigatran for 3 
months.  Dyspnoe  was  slightly  better.                                    
Discussion
Pulmonary vein stenosis (PVs) is a rare but significant complication after RF ablation of atrial 
fibrillation that poses a diagnostic challenge for the clinicians and can happen in 1-3 percent of 
cases with post RF ablation of pulmonary veins [6,7]. The incidence depends on the ablation 
strategy and the use of the energy.  Generally, it can be diagnosed by noninvasive or invasive 
image techniques.  So far, multidetection computer tomography (MDCT), TEE and magnetic 
resonance imaging (MRI) are the best ways to show the anatomy and morphology of LAA 
which can be used preprocedural and intraprocedural styles to guide the correct placement of 
occluder  implantation  [9,10].                                      
A recent  study has  shown that  LAA morphology is  classified  as  Chicken Wing (18.3%), 
WindSock (46.7%), Cauliflower  (29.1%) and Cactus  type (5.9%) [9,10].  Interestingly,  the 
Chicken Wing LAA morphology has demonstrated higher potentials  for thromboembolism 
compared to other morphologies [11].  In patients with high risk of thromboembolization and 
bleeding, the LAA occluder is an alternative approach to reduce potential embolism and avoid 
the bleeding due to anticoagulant. In clinical practices, there are two different LAA occluder 
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devices  {WATCHMAN  devices  (Atritech  Inc.,  Plymouth,  Minnesota)}  and  {Amplatzer 
Cardiac Plug (ACP) devices (AGA Medical Corp., Minneapolis, MN)}. So far, there is very 
limited information about LAA Occluders' effect on the left-sided PVs. Anatomically the left-
sided PVs is located posterior to the LAA with a narrow ridge between them. Generally the 
ridge is about 5-7 mm in diameter. The LAA occluder may theoretically have adverse effects 
on the left-sided PV. To our knowledge, this is the first case report of such a complication 
after implanting an LAA occluder in literature;  however, the incidence of pulmonary vein 
stenosis (PVs) and natural progression over time are still unknown. Therefore, it should be 
taken into consideration that implantation of ACP may have an influence on the left-sided 
PVs.
Conclusion
With increasing the frequency of RF ablation, one should consider the risk of PV Stenosis and 
control the patient after procedure to diagnose the symptoms as soon as possible. Recently, 
LAA occlusion is steadily used in clinical practice to prevent thromboembolism and reduce 
the bleeding risk in  high-risk patients.  In the present  case,  PVs was identified  after  LAA 
occlusion  implantation  and  was  diagnosed  with  preprocedural  evaluation  via  MDCT, 
intraprocedural TEE and invasive PV angiography. This patient was also symptomatic (had 
exertional dyspnoe) which became more sever after LAA Occluder implantation.  In addition, 
we couldn't identify the exact size of Occluder, but we guessed an oversized occluder should 
have been implanted.  Also,  complete  PV isolation was successfully  performed which was 
guided by PV angiography and impedance mapping. This may provide new ablation strategy 
to avoid unnecessary and unintended ablation within the PVs. Finally, systematic studies with 
large population are required to demonstrate the incidence and the progress of PV stenosis 
after  LAA  occluder  implantation.                                              
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